- Isracann Biosciences ( OTCPK:ISCNF ) has announced that it has facilitated its first shipment of cannabis strains to Israel.
- The agreement for genetics is directly between United Greeneries, a licensed Canadian producer of high calibre craft cannabis, and Intelicanna, a licensed Israeli medical cannabis grower and brand.
- Under a revenue sharing agreement, United Greeneries shall be responsible for cultivation and genetics support, with in-country support provided by Isracann.
- "We have been working with Intelicanna to have everything ready to receive the clones and expedite the process of scaling up to full production. In a short timeline, Canadian quality cannabis will be grown in Israel." said CEO Phil Floucault.
For further details see:
Isracann Bioscience facilitates cannabis genetics shipment to Israel